MIAX enters this week with a pointed contradiction: insiders cashed out aggressively in the days immediately after a strong earnings beat, yet the company just announced a clearing and settlement agreement with the Options Clearing Corporation — a structural milestone that could reshape its market position.
The insider selling is the week's most tangible signal. In a concentrated cluster on May 4, every member of the senior leadership team sold shares, from the CEO and Chairman Tom Gallagher to the CFO, CIO, General Counsel, Chief Strategy Officer, and Chief Compliance Officer. Combined, that single day saw over $7.5 million in executive disposals, with Gallagher alone selling 54,229 shares at $47.26 for roughly $2.6 million. The CFO followed on May 15 with a further $1.97 million sale at $56.36. Across the last 90 days, net insider activity comes to a positive $29 million on a net share basis, reflecting vesting and grant activity — but the directional signal from the May 4 cluster is unanimously outward. Executives selling across the board immediately after an earnings-driven re-rating is a pattern worth tracking, even when much of it reflects normal post-vest disposal.
The backdrop for those sales was genuinely strong. Q1 Adj. EPS of $0.42 beat the $0.38 estimate. Revenue of $128.6 million cleared the $122.5 million consensus. The stock jumped 4.3% the day after the print and followed through with a further 15.7% gain over the subsequent five days — the rally that the insiders sold into. The news this week of a clearing and settlement agreement with the OCC adds further strategic weight: MIAX has long operated as an exchange without a wholly-owned clearing relationship, and this arrangement tightens its infrastructure in the options market where it competes directly with and .
The analyst community raised targets after earnings but stayed largely cautious on rating. JPMorgan moved to $45 (from $41) while holding Neutral. Keefe, Bruyette & Woods went to $48 (from $40) but kept Market Perform. Only Rosenblatt pushed higher, lifting to $61 from $59 on a Buy. The mean target now sits near $49, which is actually below the current price of $53.31 — the stock has already traded through the consensus. Morgan Stanley, which carries an Overweight, raised to $50 in April. The Street broadly acknowledges the execution improvement, but the constellation of Neutrals and Market Performs signals that most analysts see limited further upside at current prices.
Factor scores back the earnings momentum story up clearly. The EPS surprise rank is in the 96th percentile — near the top of the entire universe. Forward EPS estimate momentum over 30 and 90 days each rank in the 86th–91st percentile. Those are the numbers that drove the post-earnings re-rating. Value is the counterweight: the EV/EBIT score ranks in the bottom 10th percentile, and the P/E has expanded to 32x on a 30-day change of +2.8 turns. The EV/EBITDA multiple has come in slightly to 17.5x over the past week, but the stock is trading at a premium that requires the earnings momentum to keep delivering.
Short positioning tells a quiet story. SI has fallen 31% over the past month to just 2.9% of the free float — low by any measure. Cost to borrow is negligible at 0.27%, down sharply from above 1% in mid-April. Availability is effectively unconstrained at nearly 2,910% of outstanding short interest, meaning the lending market is not even close to stressed. Options positioning is similarly relaxed: the put/call ratio at 0.50 is just fractionally below its 20-day average of 0.52, with a z-score near zero. There is no directional urgency from either the borrow market or derivatives positioning — neither bulls nor bears appear to be making a big move.
The institutional picture adds one more layer. Horizon Kinetics recently built a position of 11.76% of shares, adding over 7.7 million shares in the most recent reported quarter. T. Rowe Price holds 4.5% and also added shares. Citadel added roughly 988,000 shares. The concentrated ownership by Horizon — a firm known for holding exchange and financial infrastructure assets — provides a meaningful anchor, but also concentrates influence in a single large holder.
The next earnings date is June 16. Between now and then, what is worth watching is whether the OCC clearing agreement moves from announcement to disclosed terms, and whether the stock can hold above its own consensus price target as more analysts refresh their models on the post-Q1 data.
See the live data behind this article on ORTEX.
Open MIAX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
